Neurogene (NGNE) Change in Account Payables (2023 - 2026)
Neurogene (NGNE) posted Change in Account Payables of $2.4 million for Q1 2026, up 492.18% on a QoQ basis from $409000.0 in Q4 2025, and up 42.98% year-over-year from $1.7 million in Q1 2025.
Neurogene (NGNE) Change in Account Payables (2023 - 2026) Analysis & Trends
Neurogene's Change in Account Payables history runs 4 years deep, the most recent figure standing at $2.4 million for Q1 2026.
- Quarterly Change in Account Payables rose 42.98% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (down 8.57% YoY) and the FY2025 annual result came in at $627000.0, up 914.29% from the prior year.
- Change in Account Payables was $2.4 million for Q1 2026 at Neurogene, up from $409000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.4 million in Q1 2026 and bottomed at -$975000.0 in Q2 2025.
- A 4-year average of $279923.1 and a median of $135000.0 in 2024 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 1154.81% in 2025, while the deepest fall reached 1627.59% in 2025.
- Neurogene's Change in Account Payables stood at -$842000.0 in 2023, then surged by 50.59% to -$416000.0 in 2024, then surged by 198.32% to $409000.0 in 2025, then soared by 492.18% to $2.4 million in 2026.
- Business Quant data shows NGNE's Change in Account Payables at $2.4 million in Q1 2026, $409000.0 in Q4 2025, and -$501000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Neurogene | 17.50 Mn | 17.50 Mn | - | 2.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.42 Mn |
| Mar 31, 2026 | 2.42 Mn |
| Dec 31, 2025 | 409,000.00 |
| Dec 31, 2025 | 409,000.00 |
| Sep 30, 2025 | -501,000.00 |
| Sep 30, 2025 | -501,000.00 |
| Jun 30, 2025 | -975,000.00 |
| Jun 30, 2025 | -975,000.00 |
| Mar 31, 2025 | 1.69 Mn |
| Mar 31, 2025 | 1.69 Mn |
| Dec 31, 2024 | -416,000.00 |
| Dec 31, 2024 | -416,000.00 |
| Sep 30, 2024 | -29,000.00 |
| Sep 30, 2024 | -29,000.00 |
| Jun 30, 2024 | 233,000.00 |
| Jun 30, 2024 | 233,000.00 |
| Mar 31, 2024 | 135,000.00 |
| Mar 31, 2024 | 135,000.00 |
| Dec 31, 2023 | -842,000.00 |
| Dec 31, 2023 | -842,000.00 |